Key result
Bedside 7-variable risk score predicts pediatric DCM mortality with an AUC of ~0.93.
Why the study?
Does a point-based clinical and echocardiographic bedside risk score accurately predict mortality in children with dilated cardiomyopathy?
Cohort (n=109)
No
Does a point-based clinical and echocardiographic bedside risk score accurately predict mortality in children with dilated cardiomyopathy?
Answers are grounded in this paper and cite their sources.
This simple 7-variable bedside risk score accurately stratifies mortality risk in children with dilated cardiomyopathy using routinely available clinical, ECG, and echocardiographic parameters, aiding resource allocation in low- and middle-income settings.
Dilated cardiomyopathy (DCM) is a leading cause of pediatric heart failure and carries a substantial risk of death or heart transplantation. In low- and middle-income countries, limited access to advanced heart failure therapies and transplantation highlights the need for simple, reliable tools to identify children at highest risk. Therefore, this study aimed to identify independent predictors of mortality and develop a practical bedside risk score for mortality prediction in children with DCM. We conducted a retrospective cohort study of children with DCM treated at Dr. Sardjito Hospital, Indonesia, between 2016 and 2025. Clinical, electrocardiographic, and echocardiographic variables were evaluated for association with mortality. Independent predictors were incorporated into a point-based risk score using the Spiegelhalter-Knill-Jones method. Discriminative performance was assessed by receiver operating characteristic analysis and internal validation. Among 109 children with DCM, mortality was 33.9%. Seven independent predictors of mortality were identified: age ≥ 2 years at diagnosis, New York Heart Association/Ross functional class IV heart failure, malnutrition, requirement for vasoactive support, low-voltage electrocardiography, left ventricular end-diastolic diameter z-score > + 4, and left ventricular ejection fraction ≤ 30%. The derived score ranged from - 25 to + 28 points. A threshold score ≥ 11 accurately identified high-risk patients, achieving an area under the curve (AUC) of 0.932 (95% CI 0.886-0.977), with 73.0% sensitivity and 95.8% specificity. Internal validation demonstrated sustained performance (AUC 0.921). We developed and validated a simple, bedside mortality risk score with excellent discriminative ability for children with DCM. By relying on routinely available clinical and echocardiographic parameters, this tool enables early identification of high-risk patients and may support timely clinical decision-making and resource allocation, particularly in resource-constrained settings.
No takes yet. Share an insight, caveat, or question.
Wirawan et al. (2026) conducted a cohort in Pediatric dilated cardiomyopathy (DCM) (n=109). Point-based bedside mortality risk score (Spiegelhalter-Knill-Jones method) was evaluated on Mortality (AUC 0.932, 95% CI 0.886-0.977). A 7-variable bedside mortality risk score (threshold ≥11) predicted mortality in children with DCM with an AUC of 0.932 (95% CI 0.886-0.977; sensitivity 73.0%, specificity 95.8%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: